Background: Alzheimer's disease (AD) is the most common neurodegenerative disorder that also involves neuroinflammation in addition to many other features. Icariin (ICA) as one of the active ingredients of Chinese herbal medicine has the immunomodulating function. This study aimed to investigate the immunotherapeutic potential of ICA on AD. Methods: APP/PS1 mice and wild type C57BL/6 mice were subjected to orally ICA administration (60 mg/kg/d) for 8 months. Then, the ethological and biochemical experiments, such as Morris water maze assay, Aβ ELISA, blood T cell flow cytometry, and plasma and brain cytokines array, were conducted to evaluate the effects of ICA administration. Results: ICA significantly improved spatial learning and memory retention in APP/PS1 mice. Long-term application of ICA could also reduce hippocampus Aβ deposition, modulate the differentiation of CD4+ T cells, and modulate the release of inflammatory cytokines in plasma and brain tissue. Conclusion: ICA shows the neuroprotective effects via modulating the CD4 + T lymphocyterelated immuno-inflammatory responses in APP/PS1 mice and may be a promising drug against AD progression.
Introduction
Alzheimer's disease (AD) is the most common neurodegenerative disorder and the main cause of dementia, which is characterized by progressive memory loss and cognitive deterioration. 1 It is estimated that there is a new case every 3 s in the world, and this community is likely to rise to about 152 million people by 2050. 2 The neuropathological hallmarks of AD include the extracellular aggregation of amyloid-β (Aβ) peptide in plaques and the formation of intraneuronal neurofibrillary tangles (NFTs) by hyperphosphorylated tau protein. 3, 4 Although the mechanisms causing the neuropathological lesions are largely unknown, increasing documents initially underlined that neuroinflammation may be a major driver in the pathogenesis of AD. 5, 6 Growing evidence indicates that deposition of Aβ induces an inflammatory response by activating microglia in the brain. 7, 8 T cells have been identified in neuritic plaques and microglia in the post-mortem AD brain. 9 T cells from peripheral immune system may play a critical role in driving the neuroinflammatory changes and the associated neuronal degeneration. 10 Approximately, over 80% of the T lymphocytes in the cerebrospinal fluid are CD4 + cells. 11 Accumulating evidence suggests increased intracerebral infiltration and enhanced peripheral CD4 + T cell responses to Aβ in patients suffering from AD. 10, 12, 13 Regulatory Tcells (Tregs) have been proven to play a beneficial role in the pathophysiology of AD, by modulating microglial response to Aβ. 14 Regulation of CD4 + T cells differentiation may be a feasible way to affect the pathophysiological changes of AD. Our previous study found that human cord blood-derived stem cells could alter Tregs and alleviate neuroinflammation in AD transgenetic mice. 15 Despite current advances in the underlying mechanisms of AD, there remains no effective treatment to cure the intractable disease in clinical practice. Icariin (ICA), a natural flavonoid glucoside from Epimedium, has been proved to have various pharmacological activities, such as anti-inflammatory, 16, 17 and neuroprotective effects. 18 It presents an activity to prevent neuronal degeneration in AD animal models, by inhibiting neuronal apoptosis and Aβ deposition. 19, 20 Moreover, ICA negatively regulates the activation of T lymphocytes and pro-inflammatory cytokine profiles in CD4 + T cells. 21, 22 Meanwhile, ICA plays a regulatory effect on T-helper (Th) 17 and Tregs function. 23 These findings indicate that ICA has a potent immune regulating function to prevent chronic neuroinflammatory and might be a promising therapeutic agent for AD. Transgenic animal models of AD can simulate the behavioral and pathological changes in AD patients, thus are considered as an optimal alternative for testing novel therapeutics. 24 The APP/PS1 mouse model, first developed from a cross between the mutant amyloid precursor protein (APP) transgenic line Tg2576 and mutant presenilin 1 (PS1) transgenic mice, 25 presents substantial, age-related neuron loss in the pyramidal layer of the hippocampus, which has been widely used to explore underlying AD pathophysiology. Thus, in the present study, we attempted to investigate the specific effect of ICA on Aβ deposition and CD4 + T lymphocyte-related immuno-inflammatory responses in peripheral immune system and brain parenchyma in double transgenic APP/PS1 mice. 
Materials and methods

Morris water maze test
The Morris water maze test was performed to assess spatial learning and memory deficits. The pool (120 cm in diameter and 50 cm in height) was filled with water (opaqued with powdered milk) and maintained at 23±1°C. The test was performed 1 week after the last gavage. During the next 5 days, the navigation test was conducted 4 trials per day at 4 different start points, to find the hidden platform located under the water 1.0 cm. Each trial lasted until the animal found the platform or 60 s. Animals failing to find the platform within 60 s were guided to the hidden platform, and stayed for 15 s. Escape latency and the number of platform crossing times were recorded during the platform trials. The escape latency was recorded as 60 s. On the sixth day, the spatial probe test was performed, and the time in the target quadrant was measured. An automatic photographic recording and analysis system (Smart3.0, Panlab) was used to track and analyze behavioral parameters.
Hippocampus Aβ measurement by ELISA
After the behavioral test, mice were anesthetized using chloral hydrate (4 mL/kg). After harvesting peripheral blood, the brains were removed on ice immediately, and hippocampus was separated. Then, the hippocampus tissue was transferred to liquid nitrogen for storage. The levels of soluble and insoluble Aβ40 and Aβ42 in hippocampus were quantified according to previous procedure 26 and were determined by ELISA kit (BioLegend) in accordance with the manufacturer's instructions. Each experimental sample was run in duplicate. The data were recorded at 620 nm using a microplate reader (Biorad, USA).
Flow cytometry
Peripheral blood was harvested in tubes with heparin sodium through angular veins. After centrifuging at 1000 rpm for 30 mins at 4°C, the supernatant plasma was collected for cytokine array. For flow cytometry, the resuspended cells with PBS were isolated by mouse lymphocyte separation medium (Dakewe, China) according to the instruction. Then, cells were incubated with antibodies against CD4 + T, CD8 + T, 
Cytokine array analysis
In the present study, multiple cytokine levels in the brain and serum were measured using LEGENDplex assay (BioLegend, Beijing Ltd.) according to the instructions of the manufacturer.
Statistical analysis
The data were presented as mean±SEM. Graphs were obtained with GraphPad Prism 6, and comparisons between groups were evaluated by two-way ANOVA followed by Fisher's LDS multiple comparsions. P-value less than 0.05 was considered to be statistically significant.
Results
ICA treatment alleviates cognitive deficits in APP/PS1 mice
The Morris water maze test was used to examine the effect of ICA on the amelioration of spatial learning and cognitive deficits in APP/PS1 mice. In the place navigation test, APP/PS1 mice presented an increased escape latency to find the hidden platform compared with WT mice, but ICA treatment could significantly decrease the escape latency ( Figure 1A , P<0.05). APP/PS1 mice with ICA treatment required less time to locate the original platform position than those with saline lavage in the fourth and fifth training days ( Figure 1B ). Time spent in the target zone by APP/PS1 mice was significantly shorter than that by WT mice, while ICA treatment could significantly increase the time spent in the target section relative to APP/PS1 mice ( Figure 1C , P<0.05). APP/PS1 mice showed obviously decreased number of platform crossing times relative to WT mice ( Figure 1D , P<0.05). APP/PS1 mice under ICA treatment moderately increased the crossing times compared with untreated mice, but no significance was observed ( Figure 1D ). These findings demonstrated that ICA treatment may alleviate cognitive and memory deficits in APP/PS1 mice.
ICA treatment reduces hippocampus Aβ deposition in APP/PS1 mice
Given that Aβ deposition is a major component in AD brain and hippocampus is the key region for memory and cognitive function, we performed ELISA assay to detect both soluble and insoluble Aβ40 and Aβ42 levels in the hippocampus. The levels of insoluble Aβ40 and Aβ42 in the hippocampus of APP/PS1 mice were higher than that in the WT group (Figure 2A ) in APP/PS1 mice were tested according to our previous study. 15 As shown in Figure 3E and K, we observed that there was no statistical difference of the percentage of Tregs between the Tg and the WT groups. Whereas, ICA treatment could increase the percentage of Tregs both in the Tg and the WT groups ( Figure 3E and K).
ICA treatment alleviates neuroinflammation and regulates the release of inflammatory cytokines in the plasma and brain
Cytokine induction is a critical pathologic event in inflammatory and anti-inflammatory responses in AD. To further study the effect of ICA on immune-inflammatory response, the secretion of several pro-inflammatory cytokines (IL-1α, IL-1β, IL-6, IL-10, IL-12p70, IL-17A, IL-23, IL-27, MCP-1, IFN-β, IFN-γ, TNF-α, and GM-CSF) was detected in both plasma and brain tissues using the multiple detection kit. 
Discussion
Immune-related abnormalities in the peripheral system of patients are associated with the risk of AD. An effective intervention in immune responses might be a promising strategy to tackle this tough disorder. ICA, as an effective component of traditional Chinese medicine, has been proved to have anti-inflammation and neuroprotective effects. 27, 28 In the present study, we administered ICA for Tg mice to ameliorate AD pathology. Our results showed that ICA could improve spatial learning and memory of Tg mice, and contribute to the reduced hippocampus Aβ deposition and modulated release of proinflammatory cytokines in Tg mice. These effects might be closely related to the function of regulating CD4 + T cell a protective role in the brain, the entry of activated Th1 or Th17 cells is likely to escalate the Aβ-induced glia activation and inflammatory cascade. 10 In our study, we observed increased proportion of Th1 and Th17 cells in Tg mice indicating that the imbalance of Th cells might result in more Th1 and Th17 cells infiltrating into brain tissues. The changes in the ratio of pro-inflammatory and anti-inflammatory T cells might be a characteristic of the aggravation of AD, while this inference needs further experimental confirmation. Several herbal drugs have been reported to have antiinflammatory action, such as turmeric, 30 ginger, 31 and resveratrol. 32 In this work, we focused on the anti- We have demonstrated in this paper that the immunoinflammatory effect would be one possible mechanism. It is, however, possible that Icariin may have addition mechanism of action to affect autophagy, 34 affecting adult neurogenesis or neurogenic stem cell niche, [35] [36] [37] pg/mL pg/mL pg/mL pg/mL pg/mL IL-1β pg/mL pg/mL pg/mL pg/mL pg/mL pg/mL pg/mL pg/mL IL-10 reducing oxidative stress, 38 synaptic injury, [38] [39] [40] or epigenetic modulation. 41 Our study can be further explored by studying the CD4 + cells with the brain. In light of advanced multiplexing mass cytometry technology, this study may be expanded to gain in-depth insight at single cell or single synapse level and can offer insight into progression of disease. 40, 42 It is known that synaptic injury is cardinal and earliest features of neurogenerative diseases, including AD and Parkinson's disease. Mass synaptometry offers to study 34 markers from single synapses and thus offers unprecedented bioassay tool to study synapse. Studying ICA or turmeric or any diseasemodifying compounds administration early in disease progression may prevent the synaptic degeneration will be powerful novel assay for evaluation of drugs in neurodegeneration in general and AD in particular. 
